Mantle, D and Hargreaves, IP (2024) Efficacy and Safety of Coenzyme Q10 Supplementation in Neonates, Infants and Children: An Overview. Antioxidants, 13 (5). p. 530. ISSN 2076-3921

Preview

Text Efficacy and Safety of Coenzyme Q10 Supplementation in Neonates, Infants and Children.pdf - Published Version Available under License Creative Commons Attribution. Download (655kB) | Preview

Abstract

To date, there have been no review articles specifically relating to the general efficacy and safety of coenzyme Q10 (CoQ10) supplementation in younger subjects. In this article, we therefore reviewed the efficacy and safety of CoQ10 supplementation in neonates (less than 1 month of age), infants (up to 1 year of age) and children (up to 12 years of age). As there is no rationale for the supplementation of CoQ10 in normal younger subjects (as there is in otherwise healthy older subjects), all of the articles in the medical literature reviewed in the present article therefore refer to the supplementation of CoQ10 in younger subjects with a variety of clinical disorders; these include primary CoQ10 deficiency, acyl CoA dehydrogenase deficiency, Duchenne muscular dystrophy, migraine, Down syndrome, ADHD, idiopathic cardiomyopathy and Friedreich's ataxia.

Item Type:	Article
Uncontrolled Keywords:	ADHD; Down syndrome; Duchenne muscular dystrophy; Friedreich’s ataxia; acyl CoA dehydrogenase deficiency; coenzyme Q10; idiopathic cardiomyopathy; migraine; primary CoQ10 deficiency; ubiquinone
Subjects:	R Medicine > RJ Pediatrics > RJ101 Child Health. Child health services R Medicine > RS Pharmacy and materia medica
Divisions:	Pharmacy & Biomolecular Sciences
Publisher:	MDPI
SWORD Depositor:	A Symplectic
Date Deposited:	05 Jun 2024 14:57
Last Modified:	05 Jun 2024 15:00
DOI or ID number:	10.3390/antiox13050530
URI:	https://researchonline.ljmu.ac.uk/id/eprint/23431

View Item